AD 5

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591051

CAS#: 92455-12-4

Description: AD 5 is a bioactive chemical.

Chemical Structure

img
AD 5
CAS# 92455-12-4
Instruction

Theoretical Analysis

MedKoo Cat#: 591051
Name: AD 5
CAS#: 92455-12-4
Chemical Formula: C12H13NO4
Exact Mass: 35.08
Molecular Weight: 235.240
Elemental Analysis: C, 61.27; H, 5.57; N, 5.95; O, 27.20

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: AD5; AD-5; AD 5

IUPAC/Chemical Name: 2-Propenoic acid, 2-(((4-methoxyphenyl)acetyl)amino)-

InChi Key: DNBSASOCQLUZFR-UHFFFAOYSA-N

InChi Code: InChI=1S/C12H13NO4/c1-8(12(15)16)13-11(14)7-9-3-5-10(17-2)6-4-9/h3-6H,1,7H2,2H3,(H,13,14)(H,15,16)

SMILES Code: C=C(NC(CC1=CC=C(OC)C=C1)=O)C(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 235.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virother. 2018 May 3;7:43-51. doi: 10.2147/OV.S155946. eCollection 2018. PubMed PMID: 29765912; PubMed Central PMCID: PMC5939883.

2: Zhang W, Fu J, Ehrhardt A. Novel vector construction based on alternative adenovirus types via homologous recombination. Hum Gene Ther Methods. 2018 May 14. doi: 10.1089/hgtb.2018.044. [Epub ahead of print] PubMed PMID: 29756505.

3: Jung SY, Kang KW, Lee EY, Seo DW, Kim HL, Kim H, Kwon T, Park HL, Kim H, Lee SM, Nam JH. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018 May 5. pii: S0264-410X(18)30598-X. doi: 10.1016/j.vaccine.2018.04.082. [Epub ahead of print] PubMed PMID: 29739720.

4: Li P, Feng F, Pan E, Fan X, Yang Q, Guan M, Chen L, Sun C. Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection. Virology. 2018 Apr 19;519:86-98. doi: 10.1016/j.virol.2018.04.005. [Epub ahead of print] PubMed PMID: 29680370.

5: Metcalfe HJ, Biffar L, Steinbach S, Guzman E, Connelley T, Morrison I, Vordermeier HM, Villarreal-Ramos B. Ag85A-specific CD4(+) T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties. Vaccine. 2018 May 11;36(20):2850-2854. doi: 10.1016/j.vaccine.2018.03.068. Epub 2018 Apr 11. PubMed PMID: 29655632; PubMed Central PMCID: PMC5937909.

6: Lapuente D, Ruzsics Z, Thirion C, Tenbusch M. Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses. Vaccine. 2018 May 3;36(19):2712-2720. doi: 10.1016/j.vaccine.2018.02.075. Epub 2018 Apr 5. PubMed PMID: 29628150.

7: Webber HC, Bermudez JY, Millar JC, Mao W, Clark AF. The Role of Wnt/β-Catenin Signaling and K-Cadherin in the Regulation of Intraocular Pressure. Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1454-1466. doi: 10.1167/iovs.17-21964. PubMed PMID: 29625468; PubMed Central PMCID: PMC5858463.

8: Deng Y, Lan J, Bao L, Huang B, Ye F, Chen Y, Yao Y, Wang W, Qin C, Tan W. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 4;7(1):60. doi: 10.1038/s41426-018-0056-7. PubMed PMID: 29618723; PubMed Central PMCID: PMC5884803.

9: Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J, Keith B, Young RM, Engels B, Sorsa S, Siurala M, Havunen R, Tähtinen S, Hemminki A, June CH. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018 Apr 5;3(7). pii: 99573. doi: 10.1172/jci.insight.99573. [Epub ahead of print] PubMed PMID: 29618658; PubMed Central PMCID: PMC5928866.

10: Guo Q, Chan JF, Poon VK, Wu S, Chan CC, Hou L, Yip CC, Ren C, Cai JP, Zhao M, Zhang AJ, Song X, Chan KH, Wang B, Kok KH, Wen Y, Yuen KY, Chen W. Immunization with a Novel Human type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. J Infect Dis. 2018 Mar 29. doi: 10.1093/infdis/jiy187. [Epub ahead of print] PubMed PMID: 29617816.

11: Wang X, Wang L, Xu Y, Zhang G, Wu Y, Chen P. PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment. Oncol Lett. 2018 Mar;15(3):3828-3837. doi: 10.3892/ol.2018.7811. Epub 2018 Jan 16. PubMed PMID: 29556278; PubMed Central PMCID: PMC5843999.

12: Pancholi NJ, Weitzman MD. Serotype-specific restriction of wild-type adenoviruses by the cellular Mre11-Rad50-Nbs1 complex. Virology. 2018 May;518:221-231. doi: 10.1016/j.virol.2018.02.023. Epub 2018 Mar 15. PubMed PMID: 29547809; PubMed Central PMCID: PMC5911183.

13: Raychaudhuri U, Millar JC, Clark AF. Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma? Exp Eye Res. 2018 Mar 10;171:106-110. doi: 10.1016/j.exer.2018.03.009. [Epub ahead of print] PubMed PMID: 29535003.

14: Baraniak I, Kropff B, McLean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, Mach M, Griffiths PD, Reeves MB. Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia. J Infect Dis. 2018 Mar 8. doi: 10.1093/infdis/jiy102. [Epub ahead of print] PubMed PMID: 29528415.

15: Blass E, Aid M, Martinot AJ, Larocca RA, Kang ZH, Badamchi-Zadeh A, Penaloza-MacMaster P, Reeves RK, Barouch DH. Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection. J Virol. 2018 May 14;92(11). pii: e02103-17. doi: 10.1128/JVI.02103-17. Print 2018 Jun 1. PubMed PMID: 29514912.

16: Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, Michael N, Hu H. Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. PLoS Pathog. 2018 Feb 23;14(2):e1006888. doi: 10.1371/journal.ppat.1006888. eCollection 2018 Feb. PubMed PMID: 29474461; PubMed Central PMCID: PMC5841825.

17: Liu Z, Sun X, Xiao S, Lin Y, Li C, Hao N, Zhou M, Deng R, Ke S, Zhong Z. Characterization of aptamer-mediated gene delivery system for liver cancer therapy. Oncotarget. 2017 Dec 21;9(6):6830-6840. doi: 10.18632/oncotarget.23564. eCollection 2018 Jan 23. PubMed PMID: 29467932; PubMed Central PMCID: PMC5805518.

18: Harmon AW, Moitra R, Xu Z, Byrnes AP. Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum. PLoS One. 2018 Feb 5;13(2):e0192353. doi: 10.1371/journal.pone.0192353. eCollection 2018. PubMed PMID: 29401488; PubMed Central PMCID: PMC5798830.

19: Tutykhina I, Esmagambetov I, Bagaev A, Pichugin A, Lysenko A, Shcherbinin D, Sedova E, Logunov D, Shmarov M, Ataullakhanov R, Naroditsky B, Gintsburg A. Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts. PLoS One. 2018 Jan 29;13(1):e0191574. doi: 10.1371/journal.pone.0191574. eCollection 2018. PubMed PMID: 29377916; PubMed Central PMCID: PMC5788337.

20: Kiener R, Fleischmann M, Schwegler C, Ruzsics Z, Thirion C, Schrödel S, Asbach B, Wagner R. Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo. Sci Rep. 2018 Jan 24;8(1):1474. doi: 10.1038/s41598-018-19874-1. PubMed PMID: 29367743; PubMed Central PMCID: PMC5784015.